Important research progress in clinical practice for early breast cancer in 2024 by LI Xing, PENG Ziqi, YU Xinmiao, JIN Feng

Subjects: “…|early breast cancer|guidelines|consensus|clinical research…”
Get full text

ISMPO Guidelines for Diagnosis and Management of Early Breast Cancer by Randeep Singh, Aditya Sarin, Padmaj Kulkarni, Amit Verma, Arun Rathi, B. Koppikar Smruti, Deepika Gupta, Kanakasetty Govind Babu, Hemant Malhotra, Jyoti Bajpai, Madhavi Chandra, Purvish Parikh, Shambhavi Sharma, Sonia Badwal, Shivani Mittal, Seema Sud, Sudeep Gupta, Shona Nag, Venkat Radhakrishnan, Shyam Aggarwal

Subjects: “…early breast cancer…”
Get full text

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes by Françoise Derouane, Jérôme Ambroise, Cédric vanMarcke, Mieke Van Bockstal, Martine Berlière, Christine Galant, Hélène Dano, Médina Lougué, Elena Benidovskaya, Guy Jerusalem, Vincent Bours, Claire Josse, Jérôme Thiry, Aurélie Daumerie, Caroline Bouzin, Cyril Corbet, François P. Duhoux

Subjects: “…early breast cancer…”
Get full text

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer by Charlotta V. Mulder, Elisabeth M. Jongbloed, Marte C. Liefaard, Stavros Makrodimitris, Daan M. Hazelaar, Corine M. Beaufort, Vanja de Weerd, Lennart Mulder, Carolien H.M. van Deurzen, Gabe S. Sonke, Agnes Jager, Saskia M. Wilting, John W.M. Martens, Maurice P.H.M. Jansen, Esther H. Lips

Subjects: “…Early breast cancer…”
Get full text

Circulating Tumor Cells in Early Breast Cancer: A 10-Year Follow-Up Update by Tania Rossi, Emanuela Scarpi, Roberta Maltoni

Subjects: Get full text

Advances and controversies in the adjuvant treatment of early breast cancer by WANG Zhiqing, LIU Xiyu, FAN Lei

Subjects: “…|early breast cancer|adjuvant treatment|clinical research|research progress…”
Get full text

Alpha-L-fucosidase as a putative prognostic biomarker in breast cancer by Z. M. A. A. Hamodat, H. H. Abdulwahhab, A. R. M. T. Hamodat

Subjects: Get full text

ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY by M. Baum, A. Hackshaw, J. Houghtona, L. E. Rutqvist, T. Fornander, B. Nordenskjold, A. Nicolucci, R. Sainsburya

Subjects: Get full text

Comparison of T-DM1 and trastuzumab-pertuzumab in HER2-positive breast cancer patients with residual disease after neoadjuvant therapy: a retrospective study by Junxiao Wang, Yushuai Yu, Qisheng Lin, Xin Wang

Subjects: Get full text

Options to apply national developments in the assessment of sentinel lymph node involvement in breast cancer by M. V. Shomova, E. P. Kulikov, A. N. Demko, I. I. Vinogradov, A. D. Gerasimova, A. N. Budanov

Subjects: “…early breast cancer…”
Get full text

Cryoablation in the treatment of early breast cancer: a comprehensive analysis by Yanli Xing, Hongmei Li, Ting Yuan, Xiaojiao Zou, Bing Liang, Yangyang Ma, Lizhi Niu

Subjects: Get full text

Use of Animation Video and Clay Model for Surgical Decision-Making in Patients with Early Breast Cancer—A Prospective Study by Spandana Jagannath, Mayilvaganan Sabaretnam, Shagun Mishra, Gyan Chand, Anjali Mishra, Gaurav Agarwal

Subjects: Get full text

Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast can... by Volkmar Müller, Manuel Hörner, Marc Thill, Maggie Banys-Paluchowski, Sabine Schmatloch, Peter A. Fasching, Nadia Harbeck, Dagmar Langanke, Sabrina Uhrig, Lothar Häberle, Dorothea Fischer, Alexander Hein, Tanja N. Fehm, Chloë Goossens, Jürgen Terhaag, Uwe Heilenkötter, Peter Dall, Christian Rudlowski, Rachel Wuerstlein, Mustafa Aydogdu, Mignon-Denise Keyver-Paik, Carolin Hammerle, Natalija Deuerling, Elmar Stickeler, Bahriye Aktas, Erik Belleville, Martin Thoma, Nina Ditsch, Yasmin Baila, Christian Roos, Christian Mann, Caterina Iuliano, Sara Y. Brucker, Andreas Schneeweiss, Andreas D. Hartkopf

Subjects: “…Early breast cancer…”
Get full text

Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical... by Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Piermario Salvini, Gianluigi Ferretti, Elisabetta Cretella, Lorenzo Gianni, Claudia Bighin, Angela Toss, Angela Toss, Claudio Zamagni, Patrizia Vici, Costanza De Rossi, Antonio Russo, Giancarlo Bisagni, Alessio Schirone, Lucia Borgato, Anna Cariello, Claudia Cappelletti, Roberto Bordonaro, Saverio Cinieri, Alessandra Modena, Matteo Valerio, Maria Francesca Alvisi, Irene De Simone, Francesca Galli, Eliana Rulli, Anna Santoni, Matteo Verzè, Fabrizio Nicolis

Subjects: Get full text

Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy by Ta-Chung Chao, Deanna Gracia, Chan-Heng Ho, Hao-Yang Chen, Chi-Cheng Huang, Ling-Ming Tseng

Subjects: “…Early breast cancer…”
Get full text

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer by Iñaki Comino-Méndez, Jesús Velasco-Suelto, Javier Pascual, Esperanza López-López, Maria Elena Quirós-Ortega, Celia Gaona-Romero, Alejandro Martín-Muñoz, Patricia Losana, Yanira Heredia, Emilio Alba, Angel Guerrero-Zotano

Subjects: Get full text

Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer by Joyce O'Shaughnessy, Sara M. Tolaney, Denise A. Yardley, Lowell Hart, Pedram Razavi, Peter A. Fasching, Wolfgang Janni, Lee Schwartzberg, Julia Kim, Murat Akdere, Courtney McDermott, Aamir Khakwani, Purnima Pathak, Stephanie L. Graff

Subjects: “…HR+/HER2-early breast cancer…”
Get full text

Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐... by Ming‐Han Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, Po‐Hsiang Huang, I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu

Subjects: Get full text

The role of Taxotere in adjuvant therapy for early breast cancer by I. V. Kolyadina, I. V. Poddubnaya

Subjects: “…early breast cancer…”
Get full text

Case Report: Hepatic sarcoidosis-like reaction from neoadjuvant pembrolizumab in early-stage triple-negative breast cancer by Yujing Tan, Yu Wang, Xiaoyan Liu, Qin Ma, Cheng Zeng, Aihua Zhu, Xiaoying Sun, Fei Ma, Jiani Wang

Subjects: Get full text